Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chi-Joan How, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. How J, Ren S, Lombardi-Story J, Bergeron M, Foster J, Amrein PC, Brunner AM, Fathi AT, Hock H, Khachatryan A, Kikuchi H, Ng MR, Moran J, Narayan R, Neuberg D, Ramos A, Som T, Vartanian M, Chen YB, Duda DG, Hobbs GS. A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies. EJHaem. 2022 May; 3(2):434-442. PMID: 35846042; PMCID: PMC9175677.
  2. How J, Gallagher KME, Liu Y, Katsis K, Elder EL, Larson RC, Leick MB, Neuberg D, Maus MV, Hobbs GS. Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients. Leukemia. 2022 04; 36(4):1176-1179. PMID: 35217807; PMCID: PMC8873343.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  3. How J, Venkataraman V, Hobbs GS. Blast and accelerated phase CML: room for improvement. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):122-128. PMID: 34889372; PMCID: PMC8791122.
    Citations:    Fields:    Translation:Humans
  4. Naranbhai V, Pernat CA, Gavralidis A, St Denis KJ, Lam EC, Spring LM, Isakoff SJ, Farmer JR, Zubiri L, Hobbs GS, How J, Brunner AM, Fathi AT, Peterson JL, Sakhi M, Hambelton G, Denault EN, Mortensen LJ, Perriello LA, Bruno MN, Bertaux BY, Lawless AR, Jackson MA, Niehoff E, Barabell C, Nambu CN, Nakajima E, Reinicke T, Bowes C, Berrios-Mairena CJ, Ofoman O, Kirkpatrick GE, Thierauf JC, Reynolds K, Willers H, Beltran WG, Dighe AS, Saff R, Blumenthal K, Sullivan RJ, Chen YB, Kim A, Bardia A, Balazs AB, Iafrate AJ, Gainor JF. Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study. J Clin Oncol. 2022 01 01; 40(1):12-23. PMID: 34752147.
    Citations: 12     Fields:    Translation:HumansCells
  5. How J, Story C, Ren S, Neuberg D, Rosovsky RP, Hobbs GS, Connors JM. Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients. Blood Cancer J. 2021 11 05; 11(11):176. PMID: 34741012; PMCID: PMC8571422.
    Citations: 2     Fields:    Translation:Humans
  6. How J, Hobbs G. Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera. Curr Hematol Malig Rep. 2021 10; 16(5):473-482. PMID: 34478054.
    Citations: 1     Fields:    Translation:HumansAnimals
  7. How J, Story C, Connors JM. Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants. Postgrad Med. 2021 Jun; 133(5):508-516. PMID: 33480813.
    Citations:    Fields:    Translation:HumansPHPublic Health
  8. How J, Leiva O, Bogue T, Fell GG, Bustoros MW, Connell NT, Connors JM, Ghobrial IM, Kuter DJ, Mullally A, Neuberg D, Zwicker JI, Fogerty AE, Hobbs GS. Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. Leuk Res. 2020 11; 98:106459. PMID: 33022566.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  9. How J, Hobbs GS. A Practical Guide for Using Myelofibrosis Prognostic Models in the Clinic. J Natl Compr Canc Netw. 2020 09; 18(9):1271-1278. PMID: 32886896.
    Citations:    Fields:    Translation:Humans
  10. How J, Hobbs G. Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature. Cancers (Basel). 2020 Jul 18; 12(7). PMID: 32708474.
    Citations: 13     
  11. How J, Hobbs GS, Mullally A. Mutant calreticulin in myeloproliferative neoplasms. Blood. 2019 12 19; 134(25):2242-2248. PMID: 31562135; PMCID: PMC6923668.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  12. How J, Johnson PC, Corrales CE, Wright K, Justicz N, Chen JX, Sperling AS, Connell NT. Plasmacytoma presenting as jugular foramen tumor in a young woman with multiple myeloma. Am J Hematol. 2019 06; 94(6):728-732. PMID: 30916796.
    Citations:    Fields:    Translation:Humans
  13. Fowles JS, How J, Allen MJ, Oh ST. Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera. Leukemia. 2019 06; 33(6):1522-1526. PMID: 30635625.
    Citations: 6     Fields:    Translation:Humans
  14. How J, Vij KR, Ebadi M, DeFor TE, Romee R, Dolan MM, Ustun C, Weisdorf DJ, Linden MA, Rashidi A. Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. Am J Hematol. 2018 12; 93(12):E381-E383. PMID: 30144151; PMCID: PMC6239215.
    Citations: 1     Fields:    Translation:Humans
  15. How J, Trinkaus KM, Oh ST. Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis. Br J Haematol. 2018 10; 183(2):310-313. PMID: 29048104.
    Citations: 10     Fields:    Translation:Humans
  16. How J, Mann J, Laczniak AN, Baggstrom MQ. Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature. Clin Lung Cancer. 2017 07; 18(4):354-363. PMID: 28245967.
    Citations: 29     Fields:    Translation:Humans
  17. How J, Slade M, Vu K, DiPersio JF, Westervelt P, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Romee R. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia. Biol Blood Marrow Transplant. 2017 Apr; 23(4):648-653. PMID: 28087457; PMCID: PMC5514180.
    Citations: 13     Fields:    Translation:HumansCells
  18. How J, Zhou A, Oh ST. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Ther Adv Hematol. 2017 Mar; 8(3):107-118. PMID: 28246554.
    Citations: 13     
  19. How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature. Neurologist. 2016 Nov; 21(6):112-117. PMID: 27801773.
    Citations: 19     Fields:    Translation:Humans
  20. How J, Azar MM, Meyer JP. Are Nectarines to Blame? A Case Report and Literature Review of Spontaneous Bacterial Peritonitis Due to Listeria monocytogenes. Conn Med. 2015 Jan; 79(1):31-6. PMID: 25960571.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  21. How J, Brown JR, Saylor S, Rimm DL. Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer. Histochem Cell Biol. 2014 Aug; 142(2):195-204. PMID: 24429833.
    Citations: 6     Fields:    Translation:HumansCells
  22. Sheridan MA, How J, Araujo M, Schamberg MA, Nelson CA. What are the links between maternal social status, hippocampal function, and HPA axis function in children? Dev Sci. 2013 Sep; 16(5):665-75. PMID: 24033572.
    Citations: 27     Fields:    Translation:Humans
  23. Hsu MY, Rovinsky SA, Lai CY, Qasem S, Liu X, How J, Engelhardt JF, Murphy GF. Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. Lab Invest. 2008 Aug; 88(8):842-55. PMID: 18560367.
    Citations: 24     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
How's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (133)
Co-Authors (39)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.